Concepedia

Timothy J. Colby

TJ

11

Publications

1.3K

Citations

10

H-Index

1993

Active since

Affiliations

Torrey Pines Institute For Molecular Studies(Current)

Fate Therapeutics (United States)

PDL BioPharma (United States)

Timothy J. Colby is an author at Torrey Pines Institute For Molecular Studies specializing in medicine, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

1993–2008

11

Publications

11

A Receptor for the Malarial Parasite <i>Plasmodium vivax</i> : the Erythrocyte Chemokine Receptor

Richard Horuk, Chetan E. Chitnis, Walter C. Darbonne et al. · Science · 1993 · 590 citations

Design, Synthesis, and Characterization of a Series of Cytochrome P<sub>450</sub>3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver<sup>§</sup>

Mark D. Erion, K. Raja Reddy, Serge H. Boyer et al. · Journal of the American Chemical Society · 2004 · 157 citations

Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain.

C A Hébert, Anan Chuntharapai, McRae J. Smith et al. · Journal of Biological Chemistry · 1993 · 130 citations · Full text

, , +19

Liver-Targeted Drug Delivery Using HepDirect Prodrugs

Mark D. Erion, Paul D. van Poelje, Deidre A. MacKenna et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 117 citations

The human erythrocyte inflammatory peptide (chemokine) receptor. Biochemical characterization, solubilization, and development of a binding assay for the soluble receptor

Richard Horuk, Timothy J. Colby, Walter C. Darbonne et al. · Biochemistry · 1993 · 98 citations

Rows per page

1–5 of 11